Search Result

Results for "

DL-Glyceraldehyde-<sup>13</sup>C,d

" in MedChemExpress (MCE) Product Catalog:

By Targets:	5 alpha Reductase (2) 5-HT Receptor (14) Acetolactate Synthase (ALS) (1) Acyltransferase (1) ADC Antibody (15) ADC Cytotoxin (11) ADC Linker (1) Adenosine Receptor (2) Adrenergic Receptor (11) Akt (3) ALCAM/CD166 (1) Aldehyde Dehydrogenase (ALDH) (1) Amino Acid Derivatives (1) Aminopeptidase (8) AMPK (1) Amyloid-β (2) Anaplastic lymphoma kinase (ALK) (2) Androgen Receptor (6) Angiotensin Receptor (2) Antibiotic (54) Antibody-Drug Conjugates (ADCs) (13) Apelin Receptor (APJ) (6) Apical Sodium-Dependent Bile Acid Transporter (1) Apoptosis (102) Arenavirus (1) Aryl Hydrocarbon Receptor (4) Aurora Kinase (4) Autophagy (92) Bacterial (78) Bcl-2 Family (1) Bcr-Abl (3) BCRP (1) Biochemical Assay Reagents (15) Btk (3) c-Fms (2) c-Kit (5) c-Myc (1) Calcineurin (2) Calcium Channel (22) Cannabinoid Receptor (3) Carbonic Anhydrase (2) Caspase (3) CCR (1) CD19 (18) CD2 (2) CD20 (18) CD22 (10) CD276/B7-H3 (2) CD28 (12) CD3 (35) CD38 (19) CD47 (23) CD6 (1) CD73 (39) CD74 (1) CDK (1) Complement System (16) COX (17) CRAC Channel (1) CRISPR/Cas9 (1) CTLA-4 (1) CXCR (6) Cyclophilin (4) Cytochrome P450 (11) Dengue virus (1) Dipeptidyl Peptidase (6) Disulfidptosis (1) DNA/RNA Synthesis (62) Dopamine Receptor (10) Drug Metabolite (11) Drug-Linker Conjugates for ADC (6) Dynamin (1) E1/E2/E3 Enzyme (2) E3 Ligase Ligand-Linker Conjugates (1) EAAT (1) EBV (1) EGFR (7) Elastase (1) Endogenous Metabolite (456) Epigenetic Reader Domain (4) ERK (3) Estrogen Receptor/ERR (10) FAAH (1) Factor Xa (1) FAK (1) Ferroptosis (23) FGFR (5) FKBP (1) Flavivirus (2) FLT3 (2) Fluorescent Dye (7) Fungal (8) FXR (2) G protein-coupled Bile Acid Receptor 1 (2) GABA Receptor (6) Galectin (1) Gap Junction Protein (1) Glucocorticoid Receptor (12) Glutaminase (1) Glutathione Reductase (1) Glutathione S-transferase (1) GlyT (1) GnRH Receptor (1) GSK-3 (1) HBV (4) HCV (7) HCV Protease (1) HDAC (6) Hexokinase (2) HIF/HIF Prolyl-Hydroxylase (6) Histamine Receptor (12) Histone Acetyltransferase (2) Histone Demethylase (3) Histone Methyltransferase (3) HIV (47) HIV Integrase (1) HIV Protease (3) HMG-CoA Reductase (HMGCR) (2) HPV (2) HSP (1) HSV (9) IFNAR (8) IGF-1R (1) iGluR (11) IKK (3) Imidazoline Receptor (2) Influenza Virus (16) Insulin Receptor (1) Integrin (9) Interleukin Related (28) IRAK (2) Isotope-Labeled Compounds (667) Itk (2) JAK (3) Keap1-Nrf2 (2) Kinesin (1) Lactate Dehydrogenase (1) LAG-3 (1) Leukotriene Receptor (3) Ligands for E3 Ligase (3) Liposome (7) Lipoxygenase (2) LPL Receptor (2) mAChR (2) MAP4K (2) MAPKAPK2 (MK2) (1) MEK (1) mGluR (12) Microtubule/Tubulin (9) Mitochondrial Metabolism (2) Mitophagy (17) MMP (1) MNK (1) Molecular Glues (5) Monoamine Oxidase (1) mTOR (1) Na+/K+ ATPase (2) nAChR (2) NADPH Oxidase (2) Necroptosis (1) Neprilysin (2) Neurokinin Receptor (1) NF-κB (13) NO Synthase (13) Notch (2) NTPDase (4) Nucleoside Antimetabolite/Analog (47) Opioid Receptor (5) Orexin Receptor (OX Receptor) (2) Orthopoxvirus (8) Oxidative Phosphorylation (1) P-glycoprotein (3) P2X Receptor (2) P2Y Receptor (4) p38 MAPK (2) PAI-1 (1) PAK (2) Parasite (19) PARP (1) PD-1/PD-L1 (25) PDGFR (6) Phosphatase (11) Phosphodiesterase (PDE) (2) Phospholipase (5) PI3K (3) Piezo Channel (1) PKC (3) PKD (1) Polo-like Kinase (PLK) (1) Potassium Channel (10) PPAR (3) Progesterone Receptor (7) Prolyl Endopeptidase (PREP) (1) Prostaglandin Receptor (3) PROTAC Linkers (2) PROTACs (2) Proteasome (1) Proton Pump (2) Pyroptosis (2) RAD51 (2) Radionuclide-Drug Conjugates (RDCs) (4) Raf (3) RAR/RXR (14) Reactive Oxygen Species (27) RET (2) Reverse Transcriptase (5) ROCK (1) ROR (4) ROS Kinase (1) RSV (1) SARS-CoV (21) Serotonin Transporter (2) SHP2 (2) Sirtuin (4) Small Interfering RNA (siRNA) (100) Sodium Channel (12) Src (2) STAT (5) STING (4) TGF-beta/Smad (4) TGF-β Receptor (4) Thrombin (3) Thrombopoietin Receptor (1) Thymidylate Synthase (2) Thyroid Hormone Receptor (5) Tie (1) TNF Receptor (50) Toll-like Receptor (TLR) (6) Topoisomerase (2) Trk Receptor (3) TRP Channel (4) Tyrosinase (3) VD/VDR (3) VEGFR (12) Virus Protease (2) Wnt (1) β-catenin (1)
By Research Areas:	Cancer (648) Cardiovascular Disease (70) Endocrinology (48) Infection (182) Inflammation/Immunology (424) Metabolic Disease (244) Neurological Disease (145)
Click Chemistry:	Labeling and Fluorescence Imaging (2) Azide (4) Tetrazine (1) Alkynes (5)
Oligonucleotides:	Aptamers (2) Pre-designed siRNA Sets (100) CpG ODNs (8) mRNA (3) Solubilizing Agents (1) Cationic Lipids (1) Phospholipids (1) Antisense Oligonucleotides (2) siRNAs (100)

1670

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

MCE Kits

457

Inhibitory Antibodies

155

Natural
Products

2314

Recombinant Proteins

929

Isotope-Labeled Compounds

290

Antibodies

Click Chemistry

118

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-128748

*DL-Glyceraldehyde*	Endogenous Metabolite	Others
DL-Glyceraldehyde is a monosaccharide. DL-Glyceraldehyde is the simplest aldose. DL-Glyceraldehyde can be used for various biochemical studies .

HY-113054

DL-Glyceraldehyde 3-phosphate	Acyltransferase Bacterial Endogenous Metabolite	Infection Metabolic Disease
DL-Glyceraldehyde 3-phosphate is an intermediate in several metabolic pathways, including glycolysis and gluconeogenesis. DL-Glyceraldehyde 3-phosphate is a potent inhibitor of the growth of *E. coli. DL-Glyceraldehyde* 3-phosphate is a competitive inhibitor of the acyltransferase .

HY-128748S2

DL-Glyceraldehyde-13C,d	Isotope-Labeled Compounds Endogenous Metabolite	Others
DL-Glyceraldehyde- ¹³C,d is the deuterium and ¹³C labeled DL-Glyceraldehyde[1].

HY-131921

DL-Glyceraldehyde 3-phosphate diethyl acetal barium	Biochemical Assay Reagents	Endocrinology
DL-Glyceraldehyde 3-phosphate diethyl acetal barium is an Aspartate Aminotransferase isozyme inhibitor .

HY-128748S4

DL-Glyceraldehyde-13C3	Isotope-Labeled Compounds	Others
DL-Glyceraldehyde- ¹³C₃ is the ¹³C labled DL-Glyceraldehyde (HY-128748) . DL-Glyceraldehyde is an organic compound.

HY-128748S

DL-Glyceraldehyde-1-13C	Isotope-Labeled Compounds Endogenous Metabolite	Others
DL-Glyceraldehyde-1- ¹³C is the ¹³C labeled DL-Glyceraldehyde[1].

HY-128748S1

DL-Glyceraldehyde-2-13C	Isotope-Labeled Compounds Endogenous Metabolite	Others
DL-Glyceraldehyde-2- ¹³C is the ¹³C labeled DL-Glyceraldehyde[1].

HY-W145525

DL-Glyceraldehyde diethyl acetal 3,3-Diethoxy-1,2-propanediol	Biochemical Assay Reagents	Others
DL-Glyceraldehyde Diethyl Acetal is a biochemical reagent that can be used as a biological material or organic compound for life science related research.

HY-B0202S4

Irbesartan-13C,d4 SR-47436-<sup>13sup>C,d₄; BMS-186295-<sup>13sup>C,d₄	Angiotensin Receptor Apoptosis Isotope-Labeled Compounds	Cardiovascular Disease
Irbesartan- ¹³C,d₄ (SR-47436- ¹³C,d₄; BMS-186295- ¹³C,d₄) is ¹³C-labeled Irbesartan (HY-B0202) .

HY-B0389S19

D-Glucose-13C,d Glucose-<sup>13sup>C,d; D-(+)-Glucose-<sup>13sup>C,d; Dextrose-<sup>13sup>C,d	Endogenous Metabolite	Metabolic Disease Cancer
D-Glucose- ¹³C,d is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sign

HY-10219S1

Rapamycin-13C,d3 Sirolimus-<sup>13sup>C,d₃; AY-22989-<sup>13sup>C,d₃	Isotope-Labeled Compounds	Others
Rapamycin- ¹³C,d₃ (Sirolimus- ¹³C,d₃; AY-22989- ¹³C,d₃) is the ¹³C and deuterium labeled Rapamycin (HY-10219) . Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC₅₀ of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1 . Rapamycin is an autophagy activator, an immunosuppressant .

HY-13318S1

Oseltamivir acid-13C,d3 GS 4071-<sup>13sup>C,d₃; Ro 64-0802-<sup>13sup>C,d₃; Oseltamivir carboxylate-<sup>13sup>C,d₃	Isotope-Labeled Compounds Drug Metabolite Influenza Virus	Infection
Oseltamivir acid-13C,d3 (GS 4071-13C,d3; Ro 64-0802-13C,d3) is a 13C- and deuterium-labeled Oseltamivir acid (HY-13318). Oseltamivir acid is the active metabolite of Oseltamivir phosphate and inhibits influenza virus neuraminidase (IC₅₀=2 nM). Oseltamivir acid is orally active and can be used to study influenza A/B infections .

HY-W011240S

Hydroflumethiazide-13C,d2 Methforylthiazidine-<sup>13sup>C,d₂; Rontyl-<sup>13sup>C,d₂	Isotope-Labeled Compounds	Others
Hydroflumethiazide- ¹³C,d₂ is the deuterium and ¹³C labeled Hydroflumethiazide[1].

HY-N0378S6

D-Mannitol-13C,d2 Mannitol-<sup>13sup>C,d₂; Mannite-<sup>13sup>C,d₂	Isotope-Labeled Compounds Apoptosis Endogenous Metabolite	Metabolic Disease Cancer
D-Mannitol- ¹³C,d₂ is the deuterium and ¹³C labeled D-Mannitol.

HY-B0002BS2

Ondansetron-13C,d3 GR 38032-<sup>13sup>C,d₃; SN 307-<sup>13sup>C,d₃	Isotope-Labeled Compounds 5-HT Receptor	Neurological Disease
Ondansetron- ¹³C,d₃ is the ¹³C- and deuterium labeled Ondansetron[1].

HY-15651S

Alvelestat-13C,d3 AZD9668-<sup>13sup>C,d₃	Elastase Isotope-Labeled Compounds	Inflammation/Immunology
Alvelestat- ¹³C,d₃ (AZD9668- ¹³C,d₃) is ¹³C-labeled Alvelestat (HY-15651) .

HY-17413S1

Zidovudine-13C,d3 Azidothymidine-<sup>13sup>C,d₃; AZT-<sup>13sup>C,d₃; ZDV-<sup>13sup>C,d₃	Isotope-Labeled Compounds HIV CRISPR/Cas9	Infection
Zidovudine- ¹³C,d₃ is the ¹³C- and deuterium labeled Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine-13C,d3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-13693S2

Mometasone furoate-13C,d6 Sch32088-<sup>13sup>C,d₆	Glucocorticoid Receptor Isotope-Labeled Compounds	Cancer
Mometasone furoate- ¹³C,d₆ (Sch32088- ¹³C,d₆) is ¹³C-labeled Mometasone furoate (HY-13693) .

HY-B0330S2

Levofloxacin-13C,d3 (-)-Ofloxacin-<sup>13sup>C,d₃	Isotope-Labeled Compounds Bacterial Antibiotic	Infection
Levofloxacin- ¹³C,d₃ is the ¹³C- and deuterium labeled Levofloxacin.

HY-121259S

Doxorubicinol-13C,d3 TFA Adriamycinol-<sup>13sup>C,d₃ TFA; DXR-OL-<sup>13sup>C,d₃ TFA	Endogenous Metabolite	Others
Doxorubicinol- ¹³C,d₃ (TFA) is the deuterium and ¹³C labeled Doxorubicinol TFA[1].

HY-125818S2

Cytidine-5'-triphosphate-13C,d1 dilithium Cytidine triphosphate-<sup>13sup>C,d<sup>1sup> dilithium; 5'-CTP-<sup>13sup>C,d<sup>1sup> dilithium	Isotope-Labeled Compounds DNA/RNA Synthesis Nucleoside Antimetabolite/Analog Endogenous Metabolite	Infection Cancer
Cytidine-5'-triphosphate- ¹³C,d₁ (Cytidine triphosphate- ¹³C,d₁ dilithium; 5'-CTP- ¹³C,d₁) dilithium is deuterium and ¹³C-labeled Cytidine-5'-triphosphate (HY-125818). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule?in the de novo?pyrimidine biosynthetic pathway in?T. gondii.

HY-13683S1

Mifepristone-13C,d3 RU486-<sup>13sup>C,d₃; RU 38486-<sup>13sup>C,d₃	Isotope-Labeled Compounds Progesterone Receptor Glucocorticoid Receptor NO Synthase Autophagy	Endocrinology Cancer
Mifepristone- ¹³C,d₃ is the ¹³C- and deuterium labeled Mifepristone. Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro assay[1]. Mifepristone-13C,d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-B0389S25

D-Glucose-13C,d1 Glucose-<sup>13sup>C,d₁; D-(+)-Glucose-<sup>13sup>C,d₁; Dextrose-<sup>13sup>C,d₁	Endogenous Metabolite	Metabolic Disease Cancer
D-Glucose- ¹³C,d is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sig

HY-G0007S1

Omeprazole sulfone-13C,d3 Omeprazole sulfone-<sup>13sup>C,d₃; Omeprazole sulphone-<sup>13sup>C,d₃	Isotope-Labeled Compounds Drug Metabolite	Others
Omeprazole metabolite Omeprazole sulfone- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole metabolite Omeprazole sulfone[1].

HY-18252S

Avanafil-13C,d3 TA1790-<sup>13sup>C,d₃	Isotope-Labeled Compounds Phosphodiesterase (PDE)	Cardiovascular Disease
Avanafil- ¹³C,d₃ is the ¹³C- and deuterium labeled Avanafil.

HY-B0192S1

Alfuzosin-13C,d3 SL 77499-<sup>13sup>C,d₃	Isotope-Labeled Compounds Adrenergic Receptor	Endocrinology
Alfuzosin- ¹³C,d₃ is the ¹³C- and deuterium labeled Alfuzosin.

HY-B0740S1

Cyclobenzaprine-13C,d3 hydrochloride MK130-<sup>13sup>C,d₃ hydrochloride	Isotope-Labeled Compounds 5-HT Receptor	Neurological Disease
Cyclobenzaprine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled Cyclobenzaprine (hydrochloride).

HY-B0389S21

D-Glucose-13C,d2 Glucose-<sup>13sup>C,d₂; D-(+)-Glucose-<sup>13sup>C,d₂; Dextrose-<sup>13sup>C,d₂	Endogenous Metabolite	Metabolic Disease Cancer
D-Glucose- ¹³C,d₂ is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sig

HY-17506S1

Azithromycin-13C,d3 CP 62993-<sup>13sup>C,d₃	Bacterial Autophagy Antibiotic Isotope-Labeled Compounds	Others
Azithromycin- ¹³C,d₃ is the deuterium and ¹³C labeled Azithromycin[1].

HY-B0621S1

Triclabendazole-13C,d3 CGA89317-<sup>13sup>C,d₃	Isotope-Labeled Compounds Microtubule/Tubulin Parasite	Infection
Triclabendazole- ¹³C,d₃ is the ¹³C- and deuterium labeled Triclabendazole[1].

HY-111772S

Elexacaftor-13C,d3 VX-445-<sup>13sup>C,d₃	Isotope-Labeled Compounds	Inflammation/Immunology
Elexacaftor- ¹³C,d₃ is the deuterium labeled Elexacaftor (HY-111772)[1].

HY-14855S

Tedizolid-13C,d3 TR 700-<sup>13sup>C,d₃; Torezolid-<sup>13sup>C,d₃; DA-7157-<sup>13sup>C,d₃	Isotope-Labeled Compounds Bacterial Antibiotic	Infection
Tedizolid- ¹³C,d₃ is the ¹³C- and deuterium labeled Tedizolid. Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-B0457S2

Clomipramine-13C,d3 hydrochloride Chlorimipramine-<sup>13sup>C,d₃ hydrochloride; G-34586-<sup>13sup>C,d₃ hydrochloride; NSC-169865-<sup>13sup>C,d₃ hydrochloride	Isotope-Labeled Compounds Serotonin Transporter	Neurological Disease
Clomipramine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled Clomipramine (hydrochloride). Clomipramine (Chlorimipramine) hydrochloride is a potent 5-HT reuptake blocker with the IC50 value of 1.5 nM. Clomipramine hydrochloride is a tricyclic antidepressant that can be used for the research of depression and obsessive compulsive disorder (OCD)[1].

HY-A0023AS

Alogliptin-13C,d3 SYR-322-<sup>13sup>C,d₃	Isotope-Labeled Compounds Dipeptidyl Peptidase	Metabolic Disease Cancer
Alogliptin- ¹³C,d₃ is the deuterium labeled Alogliptin. Alogliptin is a potent and selective inhibitor of DPP-4.

HY-90001S1

Ritonavir-13C,d3 ABT 538-<sup>13sup>C,d₃; RTV-<sup>13sup>C,d₃	HIV Protease HIV SARS-CoV Apoptosis	Infection
Ritonavir- ¹³C,d₃ is the ¹³C- and deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

HY-10284S1

Linagliptin-13C,d3 BI 1356-<sup>13sup>C,d₃	Isotope-Labeled Compounds Dipeptidyl Peptidase Autophagy Ferroptosis	Metabolic Disease
Linagliptin- ¹³C,d₃ is the ¹³C- and deuterium labeled Linagliptin. Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. Linagliptin-13C,d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-B0596S

Taltirelin-13C,d3 TA-0910-<sup>13sup>C,d₃	Isotope-Labeled Compounds Apoptosis Thyroid Hormone Receptor	Neurological Disease Endocrinology
Taltirelin- ¹³C,d₃ (TA-0910- ¹³C,d₃) is ¹³C and deuterated labeled Taltirelin (HY-B0596). Taltirelin (TA0910) is a superagonist at thyrotropin-releasing hormone receptor (TRH-R) with an IC₅₀ of 910 nM and EC₅₀ of 36 nM for stimulating an increase in cytosolic Ca ²⁺ concentration (Ca ²⁺ release).

HY-10285S1

(rel)-Saxagliptin-13C,d2 TFA (rel)-BMS-477118-<sup>13sup>C,d₂ TFA	Dipeptidyl Peptidase Isotope-Labeled Compounds	Metabolic Disease
(rel)-Saxagliptin- ¹³C,d₂ ((rel)-BMS-477118- ¹³C,d₂) TFA is ¹³C-labeled Saxagliptin (HY-10285) .

HY-10250S

Triciribine phosphate-13C,d3 TCN-P-<sup>13sup>C,d₃	Isotope-Labeled Compounds	Others
Triciribine phosphate-- ¹³C,d₃ is the deuterium and ¹³C labeled Triciribine phosphate[1].

HY-66011AS4

Moxifloxacin-13C,d3 hydrochloride BAY 12-8039-<sup>13sup>C,d₃	Isotope-Labeled Compounds	Cancer
Moxifloxacin- ¹³C,d₃ hydrochloride (BAY 12-8039- ¹³C,d₃) is ¹³C and deuterated labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.

HY-126857AS1

5-Hydroxyomeprazole-13C,d2 sodium Hydroxyomeprazole-<sup>13sup>C,d₂ sodium	Isotope-Labeled Compounds Drug Metabolite	Others
5-Hydroxyomeprazole- ¹³C,d₂ sodium is ¹³C and deuterated labeled 5-Hydroxyomeprazole sodium (HY-126857A).

HY-13756S

Tacrolimus-13C,d2 FK506-<sup>13sup>C,d₂; Fujimycin-<sup>13sup>C,d₂; FR900506-<sup>13sup>C,d₂	Phosphatase FKBP Bacterial Autophagy Antibiotic	Infection Inflammation/Immunology Cancer
Tacrolimus- ¹³C,d₂ is a ¹³C-labeled and deuterium labeled Tacrolimus. Tacrolimus (FK506), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex. Tacrolimus inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].

HY-15005S

Sofosbuvir-13C,d3 PSI-7977-<sup>13sup>C,d₃; GS-7977-<sup>13sup>C,d₃	Isotope-Labeled Compounds HCV	Infection
Sofosbuvir- ¹³C,d₃ is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.

HY-N1415S1

β-Caryophyllene-13C,d2 (-)-(E)-Caryophyllene-<sup>13sup>C,d₂; (−)-β-caryophyllene-<sup>13sup>C,d₂; (−)-trans-Caryophyllene-<sup>13sup>C,d₂	Endogenous Metabolite Cannabinoid Receptor Isotope-Labeled Compounds	Cancer
β-Caryophyllene- ¹³C,d₂ is ¹³C and deuterated labeled trans,trans-2,4-Decadienal (HY-W013627). trans,trans-2,4-Decadienal is a lipid peroxidation product of linolieic acid .

HY-N0098S

Vanillin-13C,d3 p-Vanillin-<sup>13sup>C,d₃; m-Methoxy-p-hydroxybenzaldehyde-<sup>13sup>C,d₃; p-Hydroxy-m-methoxybenzaldehyde-<sup>13sup>C,d₃	Endogenous Metabolite	Others
Vanillin- ¹³C,d₃ is the ¹³C and deuterium labeled Vanillin[1]. Vanillin (p-Vanillin) is a single molecule extracted from vanilla beans and also a popular odor used widely in perfume, food and medicine[2][3].

HY-16767S1

Doravirine-13C,d3 MK-1439-<sup>13sup>C,d₃	Isotope-Labeled Compounds HIV Reverse Transcriptase	Infection
Doravirine-13C,d3 (MK-1439-13C,d3) is the deuterium labeled Doravirine (HY-16767). Doravirine (MK-1439) is a highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor with IC₅₀s of 4.5 nM, 5.5 nM and 6.1 nM against the wild type and K103N and Y181C reverse transcriptase mutants, respectively .

HY-10159S1

Nilotinib-13C,d3 AMN107-<sup>13sup>C,d₃	Isotope-Labeled Compounds Bcr-Abl Autophagy	Cancer
Nilotinib-13C,d3 is a deuterated labeled Nilotinib . Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.

HY-100427S

Imazamox-13C,d3 CL29926-<sup>13sup>C,d₃; (±)-Imazamox-<sup>13sup>C,d₃	Acetolactate Synthase (ALS) Isotope-Labeled Compounds	Others
Imazamox- ¹³C,d₃ is the ¹³C- and deuterium labeled Imazamox. Imazamox (CL29926) is a systemic herbicide that inhibits the production of acetolactate synthase (ALS) in plants with high selectivity, high activity, safety and broadspectrum activity, which would then inhibit plant growth and ultimately lead to plant death[1][2].

HY-15772S1

Osimertinib-13C,d3 AZD-9291-<sup>13sup>C,d₃; Mereletinib-<sup>13sup>C,d₃	EGFR	Cancer
Osimertinib- ¹³C,d₃ is the deuterium and ¹³C labeled Osimertinib. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively.

HY-16106S

Talazoparib-13C,d4 BMN-673-<sup>13sup>C,d₄; LT-673-<sup>13sup>C,d₄	Isotope-Labeled Compounds	Others
Talazoparib- ¹³C,d4 is ¹³C and deuterated labeled Talazoparib (HY-16106). Talazoparib is an orally active PARP 1/2 inhibitor with Ki values of 1.2 nM and 0.87 nM for inhibiting PARP1 and PARP2 enzymatic activities, respectively. Has anti-tumor activity.

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-128748

*DL-Glyceraldehyde*	Structural Classification Human Gut Microbiota Metabolites Microorganisms Ketones, Aldehydes, Acids Source classification Endogenous metabolite Saccharides Monosaccharides	Endogenous Metabolite
DL-Glyceraldehyde is a monosaccharide. DL-Glyceraldehyde is the simplest aldose. DL-Glyceraldehyde can be used for various biochemical studies .

HY-113054

DL-Glyceraldehyde 3-phosphate	Infection Structural Classification Natural Products Classification of Application Fields Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Acyltransferase Bacterial Endogenous Metabolite
DL-Glyceraldehyde 3-phosphate is an intermediate in several metabolic pathways, including glycolysis and gluconeogenesis. DL-Glyceraldehyde 3-phosphate is a potent inhibitor of the growth of *E. coli. DL-Glyceraldehyde* 3-phosphate is a competitive inhibitor of the acyltransferase .

HY-147089

PRRSV/CD163-IN-1	Infection Structural Classification Alkaloids Classification of Application Fields Other Alkaloids Source classification Endogenous metabolite Inflammation/Immunology Disease Research Fields	Bacterial Endogenous Metabolite
PRRSV/CD163-IN-1 is a *PRRSV/CD163* inhibitor. PRRSV/CD163-IN-1 can inhibit the interaction between the PRRSV glycoprotein (GP2a or GP4) and the CD163-SRCR5 domain. PRRSV/CD163-IN-1 can be used for the research of porcine reproductive and respiratory syndrome (PRRS) .

HY-P9913A

Rituximab (anti-CD20) 5+ Cited Publications	Classification of Application Fields Disease Research Fields Cancer	CD20
Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer .

HY-P9976A

Isatuximab (anti-CD38) 1 Publications Verification	Classification of Application Fields Disease Research Fields Cancer	CD38
Isatuximab (anti-CD38) is a monoclonal antibody targeting the transmembrane receptor and extracellular enzyme CD38.Isatuximab induces tumor cell killing via fragment crystallizable (Fc)-dependent or Fc-independent mechanisms, including antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), and complement-dependent cytotoxicity (CDC) .

HY-P99303

Lumiliximab Anti-CD23 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	Others
Lumiliximab (Anti-CD23 Recombinant Antibody) is an anti-CD23 monoclonal antibody that inhibits allergen-induced responses .

HY-P99372

Lorvotuzumab Anti-NCAM1/ CD56 Reference Antibody (lorvotuzumab)	Classification of Application Fields Disease Research Fields Cancer	ADC Antibody
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .

HY-P99281

Bivatuzumab BIWA 4; Anti-CD44 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	Others
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against *CD44v6. CD44v6* could acts as a sarcoma target for CAR-redirected CIK cells .

HY-N12231

Carbazomycin B	Structural Classification Monophenols Microorganisms Source classification Phenols	Antibiotic Bacterial Lipoxygenase
Carbazomycin B is a bacterial metabolite and can be isolated from Streptomyces. Carbazomycin B is an antifungal and antibacterial agent. Carbazomycin B inhibits 5-lipoxygenase (5-LO) activity in extract from RBL-1 cell with the IC₅₀ Of 1.5 µM ^[1]sup>[2]sup>[3]sup>[4].

HY-N11122

7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol	Structural Classification Natural Products Rhodiola rosea Linn. Source classification Crassulaceae Plants	Others
7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol is a cuminol glycoside. 7-[α-L-Arabinopyranosyl-(1→6)-β-D-glucopyranosyloxy]cuminol can be isolated from Rhodiola rosea sup>[1].

HY-P9915

Daratumumab 1 Publications Verification Anti-Human CD38, Human Antibody	Classification of Application Fields Disease Research Fields Cancer	CD38 ADC Antibody
Daratumumab (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab has anti-multiple myeloma (MM) effect. Daratumumab impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

HY-P99266

Zanolimumab Anti-Human CD4 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	Others
Zanolimumab (Anti-Human CD4 Recombinant Antibody) is a fully human monoclonal antibody targets *CD4*. Zanolimumab effectively inhibits T-cell receptor (TCR) signal transduction. Zanolimumab can be used for the research of heumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma .

HY-P99332

Visilizumab Anti-Human CD3E Recombinant Antibody; HuM291	Classification of Application Fields Disease Research Fields Cancer	Apoptosis
Visilizumab (Anti-Human CD3E Recombinant Antibody) is a humanized low-Fc receptor binding anti-CD3 monoclonal IgG2 antibody. Visilizumab can be used for ulcerative colitis and Crohn's disease research .

HY-N8824

Maackiaflavanone	Structural Classification Flavonoids Leguminosae Flavonones Source classification Maackia amurensis Rupr. et Maxim. Plants	Others
Maackiaflavanone (compound 4) is a kind of prenylated flavanone. Maackia can be isolated from M. amurensi.

HY-P99329

Vadastuximab Anti-Human CD33 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	Others
Vadastuximab is a humanized monoclonal antibody targeting CD33. Vadastuximab can be used to synthesize an ADC compound, Vadastuximab talirine .

HY-P9915A

Daratumumab (PBS) 1 Publications Verification Anti-Human CD38, Human Antibody (PBS)	Classification of Application Fields Disease Research Fields Cancer	ADC Antibody CD38
Daratumumab (PBS) (Anti-Human CD38) is the first-in-class human-specific *anti-CD38* monoclonal antibody (IgG1). Daratumumab (PBS) has anti-multiple myeloma (MM) effect. Daratumumab (PBS) impairs MM cell adhesion, which results in an increased sensitivity of MM to proteasome inhibition .

HY-P9913

Rituximab 5+ Cited Publications Anti-Human CD20 type I, Chimeric Antibody	Classification of Application Fields Disease Research Fields Cancer	Radionuclide-Drug Conjugates (RDCs) CD20
Rituximab is an anti-CD20 chimeric monoclonal antibody used for research of certain autoimmune diseases and cancer.

HY-P99326

Tositumomab Anti-Human CD20 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	Radionuclide-Drug Conjugates (RDCs) CD20
Tositumomab is a murine IgG2a lambda monoclonal antibody directed against the CD20 antigen, which is found on the surface of normal and malignant B lymphocytes .

HY-P3260

5′-Nucleotidase, Microorganism CD73; 5′-NT	Classification of Application Fields Disease Research Fields Cancer	Endogenous Metabolite
5′-Nucleotidase, Microorganism (CD73) is an intrinsic membrane glycoprotein present as an ectoenzyme. 5′-Nucleotidase catalyzes hydrolysis of 5-nucleotides to their corresponding nucleosides .

HY-P99289

Epratuzumab Antibody hLL 2; Anti-Human CD22 Recombinant Antibody	Classification of Application Fields Disease Research Fields Cancer	CD22
Epratuzumab (Antibody hLL 2) is an anti-CD22 IgG1 monoclonal antibody. Epratuzumab is also a tumor-imaging agent and an immunomodulatory agent. Epratuzumab can induce CD22 phosphorylation. Epratuzumab has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases .

HY-P9910

Obinutuzumab GA101; Anti-Human CD20 type II, Humanized Antibody	Classification of Application Fields Disease Research Fields Cancer	CD20
Obinutuzumab (GA101) a novel glycoengineered Type II CD20 humanized IgG1 monoclonal antibody in development for non-Hodgkin lymphoma.

HY-N3872

Ethyl β-D-glucopyranoside	Scabiosa stellata L. Structural Classification Natural Products Caprifoliaceae Source classification Plants	Others
Ethyl β-D-glucopyranoside (compound 10) is a kind of phenolic compound. Ethyl β-D-glucopyranoside can be isolated from ethanolic extract of Scabiosa stellata LS.

HY-N8859

Isoiridogermanal 16-Hydroxyiridal	Structural Classification Natural Products Source classification Lridaceae Plants	Others
Isoiridogermanal can be isolated from the extract of rhizomes of Iris tectorum Maxim. Isoiridogermanal is cytotoxic with IC50 values of 11 μM and 23 μM against MCF-7 and C32 cell lines.

HY-P99363

Feladilimab Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609	Classification of Application Fields Disease Research Fields Cancer	Others
Feladilimab (Anti-ICOS/CD278 Reference Antibody (feladilimab); GSK3359609) is humanized IgG4 anti-ICOS agonist monoclonal antibody. Feladilimab binds to ICOS-expressing T cells. Feladilimab has the potential for the research of cancer .

HY-P99572

Tecaginlimab BNT-312; DuoBody-CD40x-4-1BB; GEN1042	Classification of Application Fields Disease Research Fields Cancer	TNF Receptor
Tecaginlimab (BNT-312) is a Fc-inert bispecific antibody for dual targeting and conditional stimulation of *CD40* and 4-1BB. Tecaginlimab can enhance priming and reactivation of tumor-specific immunity .

HY-P99445

Asunercept APG101; CAN008	Classification of Application Fields Disease Research Fields Cancer	TNF Receptor
Asunercept (APG101; CAN008) is a soluble CD95-Fc fusion protein targeting *CD95L. Asunercept disrupts CD95/CD95L* signaling by selectively binding to *CD95L*. Asunercept can be used in the research of glioblastoma multiforme (GBM), myelodysplastic syndrome (MDS), and graft-versus-host disease (GvHD) .

HY-N3980

Guaiol Champacol; Guaiac alcohol	Infection Structural Classification Natural Products Classification of Application Fields Source classification Distemonanthus benthamianus Baill. Plants Compositae Disease Research Fields	Autophagy RAD51
Guaiol is a sesquiterpenoid alcohol with oral activity found in various traditional Chinese medicines, exhibiting biological activities such as anti-proliferative, autophagy-promoting, insecticidal, anti-anxiety, anti-inflammatory, diuretic, and blood pressure-lowering effects. Guaiol induces apoptosis in non-small cell lung cancer cells by regulating the stability of RAD51 through autophagy modulation. Guaiol can also act directly on parasites, inhibiting their growth by affecting the kinetoplast, mitochondrial matrix and plasma membrane of the promastigotes. Guaiol kills amastigotes at an IC₅₀ of 0.01 µg/mL. Guaiol can be used in research related to cancer, infections, cardiovascular diseases, and inflammatory conditions ^{[4]sup .}

HY-N8930

Eupatorin-5-methyl ether	Structural Classification Galinsoga parviflora Cav. Flavonoids Flavones Labiatae Source classification Plants	Others
Eupatorin-5-methyl ether (TMF) can be isolated from Orthosiphon stamineus. Eupatorin-5-methyl ether is a kind of flavonoid compound. Eupatorin-5-methyl ether inhibits NO production (IC50 5.5 μM).

HY-N3980R

Guaiol (Standard)	Structural Classification Natural Products Source classification Distemonanthus benthamianus Baill. Plants Compositae	Autophagy RAD51
Guaiol (Standard) is the analytical standard of Guaiol. This product is intended for research and analytical applications. Guaiol is a sesquiterpenoid alcohol with oral activity found in various traditional Chinese medicines, exhibiting biological activities such as anti-proliferative, autophagy-promoting, insecticidal, anti-anxiety, anti-inflammatory, diuretic, and blood pressure-lowering effects. Guaiol induces apoptosis in non-small cell lung cancer cells by regulating the stability of RAD51 through autophagy modulation. Guaiol can also act directly on parasites, inhibiting their growth by affecting the kinetoplast, mitochondrial matrix and plasma membrane of the promastigotes. Guaiol kills amastigotes at an IC50 of 0.01 µg/mL. Guaiol can be used in research related to cancer, infections, cardiovascular diseases, and inflammatory conditions ^[3][4] .

HY-P99731

Milatuzumab 2 Publications Verification hLL1; MEDI-115	Classification of Application Fields Disease Research Fields Cancer	CD74
Milatuzumab (hLL1; MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death .

HY-P99395

Talacotuzumab JNJ 56022473; CSL 362	Classification of Application Fields Disease Research Fields Cancer	Interleukin Related
Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, *CD123*-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has K_Ds of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models .

HY-P99533

Urabrelimab SRF-231; SRF231	Classification of Application Fields Disease Research Fields Cancer	CD47 Interleukin Related
Urabrelimab (SRF231) is a fully human anti-CD47 monoclonal antibody that blocks the CD47-SIRP interaction .

HY-P99038

Odronextamab	Classification of Application Fields Disease Research Fields Cancer	CD20 CD3
Odronextamab is a stable humanized IgG4 *CD20* × *CD3* bispecific antibody that binds to CD3 on T cells and CD20 on B cells, triggering anti-tumor activity. Odronextamab is expected to be used in oncology research .

HY-P99623

Flotetuzumab MGD006; S80880	Classification of Application Fields Disease Research Fields Cancer	CD3
Flotetuzumab (MGD006; S80880) is an investigational *CD123/CD3* bispecific dual-affinity retargeting antibody (DART) molecule. Flotetuzumab reactivates T cells by simultaneously binding to *CD123* in target cells and *CD3* in effector T cells, leading to T-cell-mediated cytotoxicity in target cells. Flotetuzumab shows inhibitory effect on a mouse model of patient-derived xenograft (PDX) in acute myeloid leukemia (AML) .

HY-P99521

Vibecotamab XmAb14045	Classification of Application Fields Disease Research Fields Cancer	CD3
Vibecotamab (XmAb14045) is a potent bispecific antibody against *CD123* and *CD3* that stimulates T cell-mediated targeted killing of CD123-expressing cells. Vibecotamab has antitumor activity and can be used in acute myeloid leukaemia studies .

HY-P99931

Epcoritamab GEN3013	Classification of Application Fields Disease Research Fields Cancer	CD3 CD20
Epcoritamab (GEN3013) is an bispecific IgG1 antibody redirecting T-cells toward CD3×CD20 ⁺ tumor cells. Epcoritamab induces potent T-cell-mediated cytotoxicity towards B-cell NHL cell lines .

HY-P99167

Lucatumumab HCD122	Classification of Application Fields Disease Research Fields Cancer	TNF Receptor
Lucatumumab (HCD122) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research .

HY-P9961

Ofatumumab	Classification of Application Fields Disease Research Fields Cancer	CD20
Ofatumumab is a fully human anti-CD20 monoclonal antibody that induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity in CD20-expressing B lymphocytes .

HY-P99868

Duvortuxizumab MGD 011	Classification of Application Fields Disease Research Fields Cancer	CD19
Duvortuxizumab (MGD 011) is a chimeric humanized IG antibody targeting CD19 and CD3E .

HY-P99157

Omburtamab	Classification of Application Fields Disease Research Fields Cancer	CD276/B7-H3
Omburtamab is an *anti-CD276* (also known as B7-H3) monoclonal antibody, CD276 is a B7/CD28 immunoglobulin superfamily member expressed among solid human tumours. Omburtamab can bind tumor tissues and be used in various cancers research .

HY-P99400

Samalizumab ALXN 6000	Classification of Application Fields Disease Research Fields Cancer	Others
Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to *CD200* and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research .

HY-P99159

Ivuxolimab	Classification of Application Fields Disease Research Fields Cancer	Others
Ivuxolimab is an OX40 (also known as *CD134; TNFRSF4*) agonist monoclonal antibody. OX40 is a costimulatory receptor expressed on activated CD4 ⁺ and CD8 ⁺ T cells. Ivuxolimab shows antitumor activity, with potential immunostimulatory activity .

HY-P9954

Catumaxomab	Classification of Application Fields Disease Research Fields Cancer	CD3
Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .

HY-111054A

N-methyl-N-dithiocarboxyglucamine sodium MDCG sodium	Structural Classification Natural Products Classification of Application Fields Source classification Other Diseases Endogenous metabolite Disease Research Fields	Endogenous Metabolite
N-methyl-N-dithiocarboxyglucamine (MDCG) sodium mobilizes and promotes excretion of metallothionein-bound ¹⁰⁹Cd in mouse model. N-methyl-N-dithiocarboxyglucamine significantly lowers the Cd content of both the liver and kidney, which is organs most susceptible to Cd-induced toxicity .

HY-B0579

Cyclosporin A Maximum Cited Publications 115 Publications Verification Cyclosporine A; Ciclosporin A; CsA	Structural Classification Natural Products Microorganisms Classification of Application Fields Anti-aging Source classification Inflammation/Immunology Disease Research Fields Cancer	Molecular Glues Complement System Antibiotic Cyclophilin
Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC₅₀ of 5 nM . Cyclosporin A also inhibits *CD11a/CD18* adhesion .

HY-P99523

Vepsitamab AMG 199	Classification of Application Fields Disease Research Fields Cancer	CD3
Vepsitamab (AMG 199) is an anti-MUC17/CD3 BiTE antibody that binds to CD3 on T cells and MUC17 expressed on tumor cells, mediates redirected tumor cell lysis, and induces T cell activation and proliferation .

HY-P99776

Plamotamab XmAb-13676	Classification of Application Fields Disease Research Fields Cancer	CD20 CD3
Plamotamab (XmAb-13676) is a human bispecific antibody (bsAb) that binds *CD3* and *CD20. Plamotamab recruits cytotoxic T cells to kill CD20 ⁺ expressing tumor cells. Plamotamab induces a mild hematologic reaction (MR), and results in tumor regression in vivo* .

HY-P99802

Pasotuxizumab BAY 2010112; AMG 212	Classification of Application Fields Disease Research Fields Cancer	CD3
Pasotuxizumab (BAY 2010112) is a PSMA and *CD3* bispecific T-cell engager (BiTE). Pasotuxizumab binds to CD3 and PSMA with K_Ds of 9.4 nM and 47.0 nM for human CD3 and PSMA. Pasotuxizumab can be used for research of metastatic castration-resistant prostate cancer (mCRPC) .

HY-P99338

Tisagenlecleucel CTL019	Classification of Application Fields Disease Research Fields Cancer	CD19
Tisagenlecleucel (CTL019) is an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. Tisagenlecleucel targets and eliminates CD19-expressing B cells. Tisagenlecleucel can be used for the research of refractory aggressive diffuse large B-cell lymphoma .

HY-P99234

Pivekimab	Classification of Application Fields Disease Research Fields Cancer	Interleukin Related ADC Antibody
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) .

Cat. No.	Product Name	Chemical Structure

HY-10219S1

Rapamycin-13C,d3

Rapamycin- ¹³C,d₃ (Sirolimus- ¹³C,d₃; AY-22989- ¹³C,d₃) is the ¹³C and deuterium labeled Rapamycin (HY-10219) . Rapamycin (Sirolimus; AY 22989) is a potent and specific mTOR inhibitor with an IC₅₀ of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1 . Rapamycin is an autophagy activator, an immunosuppressant .

HY-128748S2

DL-Glyceraldehyde-13C,d
DL-Glyceraldehyde- ¹³C,d is the deuterium and ¹³C labeled DL-Glyceraldehyde[1].

HY-128748S4

DL-Glyceraldehyde-13C3
DL-Glyceraldehyde- ¹³C₃ is the ¹³C labled DL-Glyceraldehyde (HY-128748) . DL-Glyceraldehyde is an organic compound.

HY-128748S

DL-Glyceraldehyde-1-13C
DL-Glyceraldehyde-1- ¹³C is the ¹³C labeled DL-Glyceraldehyde[1].

HY-128748S1

DL-Glyceraldehyde-2-13C
DL-Glyceraldehyde-2- ¹³C is the ¹³C labeled DL-Glyceraldehyde[1].

HY-B0202S4

Irbesartan-13C,d4
Irbesartan- ¹³C,d₄ (SR-47436- ¹³C,d₄; BMS-186295- ¹³C,d₄) is ¹³C-labeled Irbesartan (HY-B0202) .

HY-B0389S19

D-Glucose-13C,d
D-Glucose- ¹³C,d is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sign

HY-13318S1

Oseltamivir acid-13C,d3
Oseltamivir acid-13C,d3 (GS 4071-13C,d3; Ro 64-0802-13C,d3) is a 13C- and deuterium-labeled Oseltamivir acid (HY-13318). Oseltamivir acid is the active metabolite of Oseltamivir phosphate and inhibits influenza virus neuraminidase (IC₅₀=2 nM). Oseltamivir acid is orally active and can be used to study influenza A/B infections .

HY-W011240S

Hydroflumethiazide-13C,d2
Hydroflumethiazide- ¹³C,d₂ is the deuterium and ¹³C labeled Hydroflumethiazide[1].

HY-N0378S6

D-Mannitol-13C,d2
D-Mannitol- ¹³C,d₂ is the deuterium and ¹³C labeled D-Mannitol.

HY-B0002BS2

Ondansetron-13C,d3
Ondansetron- ¹³C,d₃ is the ¹³C- and deuterium labeled Ondansetron[1].

HY-15651S

Alvelestat-13C,d3
Alvelestat- ¹³C,d₃ (AZD9668- ¹³C,d₃) is ¹³C-labeled Alvelestat (HY-15651) .

HY-17413S1

Zidovudine-13C,d3

Zidovudine- ¹³C,d₃ is the ¹³C- and deuterium labeled Zidovudine. Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), widely used to treat HIV infection. Zidovudine increases CRISPR/Cas9-mediated editing frequency. Zidovudine-13C,d3 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-13693S2

Mometasone furoate-13C,d6
Mometasone furoate- ¹³C,d₆ (Sch32088- ¹³C,d₆) is ¹³C-labeled Mometasone furoate (HY-13693) .

HY-B0330S2

Levofloxacin-13C,d3
Levofloxacin- ¹³C,d₃ is the ¹³C- and deuterium labeled Levofloxacin.

HY-121259S

Doxorubicinol-13C,d3 TFA
Doxorubicinol- ¹³C,d₃ (TFA) is the deuterium and ¹³C labeled Doxorubicinol TFA[1].

HY-125818S2

Cytidine-5'-triphosphate-13C,d1 dilithium

Cytidine-5'-triphosphate- ¹³C,d₁ (Cytidine triphosphate- ¹³C,d₁ dilithium; 5'-CTP- ¹³C,d₁) dilithium is deuterium and ¹³C-labeled Cytidine-5'-triphosphate (HY-125818). Cytidine 5′-triphosphate (Cytidine triphosphate; 5'-CTP) is a nucleoside triphosphate and serves as a building block for nucleotides and nucleic acids, lipid biosynthesis. Cytidine triphosphate synthase can catalyze the formation of cytidine 5′-triphosphate from uridine 5′-triphosphate (UTP). Cytidine 5′-triphosphate is an essential biomolecule?in the de novo?pyrimidine biosynthetic pathway in?T. gondii.

HY-13683S1

Mifepristone-13C,d3

Mifepristone- ¹³C,d₃ is the ¹³C- and deuterium labeled Mifepristone. Mifepristone (RU486) is a progesterone receptor (PR) and glucocorticoid receptor (GR) antagonist with IC50s of 0.2 nM and 2.6 nM in in vitro assay[1]. Mifepristone-13C,d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-B0389S25

D-Glucose-13C,d1
D-Glucose- ¹³C,d is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sig

HY-G0007S1

Omeprazole sulfone-13C,d3
Omeprazole metabolite Omeprazole sulfone- ¹³C,d₃ is the deuterium and ¹³C labeled Omeprazole metabolite Omeprazole sulfone[1].

HY-18252S

Avanafil-13C,d3
Avanafil- ¹³C,d₃ is the ¹³C- and deuterium labeled Avanafil.

HY-B0192S1

Alfuzosin-13C,d3
Alfuzosin- ¹³C,d₃ is the ¹³C- and deuterium labeled Alfuzosin.

HY-B0740S1

Cyclobenzaprine-13C,d3 hydrochloride
Cyclobenzaprine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled Cyclobenzaprine (hydrochloride).

HY-B0389S21

D-Glucose-13C,d2
D-Glucose- ¹³C,d₂ is the deuterium and ¹³C labeled D-Glucose. D-Glucose (Glucose), a monosaccharide, is an important carbohydrate in biology. D-Glucose is a carbohydrate sweetener and critical components of the general metabolism, and serve as critical sig

HY-17506S1

Azithromycin-13C,d3
Azithromycin- ¹³C,d₃ is the deuterium and ¹³C labeled Azithromycin[1].

HY-B0621S1

Triclabendazole-13C,d3
Triclabendazole- ¹³C,d₃ is the ¹³C- and deuterium labeled Triclabendazole[1].

HY-111772S

Elexacaftor-13C,d3
Elexacaftor- ¹³C,d₃ is the deuterium labeled Elexacaftor (HY-111772)[1].

HY-14855S

Tedizolid-13C,d3
Tedizolid- ¹³C,d₃ is the ¹³C- and deuterium labeled Tedizolid. Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome.

HY-B0457S2

Clomipramine-13C,d3 hydrochloride
Clomipramine- ¹³C,d₃ (hydrochloride) is the ¹³C- and deuterium labeled Clomipramine (hydrochloride). Clomipramine (Chlorimipramine) hydrochloride is a potent 5-HT reuptake blocker with the IC50 value of 1.5 nM. Clomipramine hydrochloride is a tricyclic antidepressant that can be used for the research of depression and obsessive compulsive disorder (OCD)[1].

HY-A0023AS

Alogliptin-13C,d3
Alogliptin- ¹³C,d₃ is the deuterium labeled Alogliptin. Alogliptin is a potent and selective inhibitor of DPP-4.

HY-90001S1

Ritonavir-13C,d3
Ritonavir- ¹³C,d₃ is the ¹³C- and deuterium labeled Ritonavir. Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS. Ritonavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 1.61 μM.

HY-10284S1

Linagliptin-13C,d3
Linagliptin- ¹³C,d₃ is the ¹³C- and deuterium labeled Linagliptin. Linagliptin is a highly potent, selective DPP-4 inhibitor with IC50 of 1 nM. Linagliptin-13C,d3 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

HY-B0596S

Taltirelin-13C,d3
Taltirelin- ¹³C,d₃ (TA-0910- ¹³C,d₃) is ¹³C and deuterated labeled Taltirelin (HY-B0596). Taltirelin (TA0910) is a superagonist at thyrotropin-releasing hormone receptor (TRH-R) with an IC₅₀ of 910 nM and EC₅₀ of 36 nM for stimulating an increase in cytosolic Ca ²⁺ concentration (Ca ²⁺ release).

HY-10285S1

(rel)-Saxagliptin-13C,d2 TFA
(rel)-Saxagliptin- ¹³C,d₂ ((rel)-BMS-477118- ¹³C,d₂) TFA is ¹³C-labeled Saxagliptin (HY-10285) .

HY-10250S

Triciribine phosphate-13C,d3
Triciribine phosphate-- ¹³C,d₃ is the deuterium and ¹³C labeled Triciribine phosphate[1].

HY-66011AS4

Moxifloxacin-13C,d3 hydrochloride
Moxifloxacin- ¹³C,d₃ hydrochloride (BAY 12-8039- ¹³C,d₃) is ¹³C and deuterated labeled Moxifloxacin (HY-66011A). Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.

HY-126857AS1

5-Hydroxyomeprazole-13C,d2 sodium
5-Hydroxyomeprazole- ¹³C,d₂ sodium is ¹³C and deuterated labeled 5-Hydroxyomeprazole sodium (HY-126857A).

HY-13756S

Tacrolimus-13C,d2
Tacrolimus- ¹³C,d₂ is a ¹³C-labeled and deuterium labeled Tacrolimus. Tacrolimus (FK506), a macrocyclic lactone, binds to FK506 binding protein (FKBP) to form a complex. Tacrolimus inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties[1].

HY-15005S

Sofosbuvir-13C,d3
Sofosbuvir- ¹³C,d₃ is the deuterium labeled Sofosbuvir. Sofosbuvir (PSI-7977) is an active inhibitor of HCV RNA replication in the HCV replicon assay, demonstrates potent anti-hepatitis C virus (HCV) activity.

HY-N1415S1

β-Caryophyllene-13C,d2
β-Caryophyllene- ¹³C,d₂ is ¹³C and deuterated labeled trans,trans-2,4-Decadienal (HY-W013627). trans,trans-2,4-Decadienal is a lipid peroxidation product of linolieic acid .

HY-N0098S

Vanillin-13C,d3
Vanillin- ¹³C,d₃ is the ¹³C and deuterium labeled Vanillin[1]. Vanillin (p-Vanillin) is a single molecule extracted from vanilla beans and also a popular odor used widely in perfume, food and medicine[2][3].

HY-16767S1

Doravirine-13C,d3
Doravirine-13C,d3 (MK-1439-13C,d3) is the deuterium labeled Doravirine (HY-16767). Doravirine (MK-1439) is a highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor with IC₅₀s of 4.5 nM, 5.5 nM and 6.1 nM against the wild type and K103N and Y181C reverse transcriptase mutants, respectively .

HY-10159S1

Nilotinib-13C,d3
Nilotinib-13C,d3 is a deuterated labeled Nilotinib . Nilotinib is an orally available Bcr-Abl tyrosine kinase inhibitor with antineoplastic activity.

HY-100427S

Imazamox-13C,d3
Imazamox- ¹³C,d₃ is the ¹³C- and deuterium labeled Imazamox. Imazamox (CL29926) is a systemic herbicide that inhibits the production of acetolactate synthase (ALS) in plants with high selectivity, high activity, safety and broadspectrum activity, which would then inhibit plant growth and ultimately lead to plant death[1][2].

HY-15772S1

Osimertinib-13C,d3
Osimertinib- ¹³C,d₃ is the deuterium and ¹³C labeled Osimertinib. Osimertinib (AZD9291) is a covalent, orally active, irreversible, and mutant-selective EGFR inhibitor with an apparent IC50 of 12 nM against L858R and 1 nM against L858R/T790M, respectively.

HY-16106S

Talazoparib-13C,d4
Talazoparib- ¹³C,d4 is ¹³C and deuterated labeled Talazoparib (HY-16106). Talazoparib is an orally active PARP 1/2 inhibitor with Ki values of 1.2 nM and 0.87 nM for inhibiting PARP1 and PARP2 enzymatic activities, respectively. Has anti-tumor activity.

HY-W011240S1

Hydroflumethiazide-15N2,13C,d2
Hydroflumethiazide- ¹⁵N₂, ¹³C,d₂ is the ¹³C- and ¹⁵N-labeled Hydroflumethiazide[1].

HY-10999S2

Trametinib-13C,d3
Trametinib- ¹³C,d₃ is the ¹³C- and deuterium labeled Trametinib. Trametinib (GSK1120212; JTP-74057) is an orally active MEK inhibitor that inhibits MEK1 and MEK2 with IC50s of about 2 nM. Trametinib activates autophagy and induces apoptosis[1][2].

HY-W097453S

6-(Methylthio)purine-13C,d3
6-(Methylthio)purine- ¹³C,d₃ is the ¹³C labeled 6-(Methylthio)purine.

HY-14369S

Elagolix-13C,d3 sodium
Elagolix- ¹³C,d₃ (sodium) is the ¹³C- and deuterium labeled Elagolix sodium. Elagolix sodium is a human GnRH receptor (GnRHR) antagonist with an IC50 and Ki of 0.25 and 3.7 nM, respectively.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Species:	Human (1204) Rhesus Macaque/Cynomolgus (1) Marmoset (2) Rhesus Macaque (144) Mouse (465) Rat (217) Cynomolgus (238) E.coli (2) Rabbit (12) Dog (1) Canine (50) Pig (1)
Tag:	SUMO (17) GST (22) Flag (45) GFP (1) His (1536) Tag Free (87) Strep (1) Avi (379) Myc (15) HSA (1) MBP (1) Trx (4) Fc (726) B2M (1)
Source:	HEK293 (2136) E. coli Cell-free (7) CHO (6) CHO (9) Sf9 insect cells (3) P. pastoris (19) Sf9 insect cells (51) E. coli (83)


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

DL-Glyceraldehyde-<sup>13</sup>C,d

Inhibitors & Agonists

Screening Libraries

Fluorescent Dye

Biochemical Assay Reagents

Peptides

MCE Kits

Inhibitory Antibodies

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Click Chemistry

Oligonucleotides

Natural
Products